Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects
Safety issues including side effects are one of the major factors causing failure of clinical trials in drug development. Here, the authors leverage information about phenotypes associated with variation in genes encoding drug targets to predict drug-treatment-related side effects.
Guardado en:
Autores principales: | Phuong A. Nguyen, David A. Born, Aimee M. Deaton, Paul Nioi, Lucas D. Ward |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/003cfedb56c34cf29e4173da6041f948 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects
por: Phuong A. Nguyen, et al.
Publicado: (2019) -
Network neighbors of drug targets contribute to drug side-effect similarity.
por: Lucas Brouwers, et al.
Publicado: (2011) -
Predicting the frequencies of drug side effects
por: Diego Galeano, et al.
Publicado: (2020) -
A side-effect free method for identifying cancer drug targets
por: Md. Izhar Ashraf, et al.
Publicado: (2018) -
Designing antifilarial drug trials using clinical trial simulators
por: Martin Walker, et al.
Publicado: (2020)